GERNWGeron Corp.

About Geron Corp. (GERNW)

Geron Corp. (GERNW) is a N/A company headquartered in FOSTER CITY, CA, United States whose shares trade over-the-counter on the Pink tier.

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis.

GERNW key facts

Ticker symbol

GERNW

Market tier

Pink

Headquarters

FOSTER CITY, CA, United States

Country of incorporation

US

Estimated market cap

$757.4K (as of Apr 11, 2025)

Shares outstanding

2,805,040

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Geron Corp. leadership

• Ronald W. Eastman — President, CEO
• David L. Greenwood — CFO , Secretary

Explore more: Pink stocks · OTC stocks starting with G